MSCLF Projected Dividend Yield
Satellos Bioscience Inc ( OTCBB : MSCLF )Satellos Bioscience is a biotechnology and drug development. Co. has two portfolios: intellectual property, trademarks and know-how under development by Pre-Arrangement Satellos (the Satellos Portfolio); and intellectual property and assets acquired through the Arrangement (the iCo Portfolio). The technologies in the Satellos Portfolio are based on biological discoveries in the area of muscle stem cells regulation and muscle regeneration. Co.'s technologies within the iCo Portfolio: Oral Amp B Delivery System, which is an oral transport technology; and iCo-008, which is a human monoclonal antibody that neutralizes eotaxin-1, a ligand to the C-C chemokine receptor type three. 20 YEAR PERFORMANCE RESULTS |
MSCLF Dividend History Detail MSCLF Dividend News MSCLF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |